Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Quick Stats
Jun 23, 202657.0
AI Score
HOLD0.93
Volume Ratio
Aug 04, 2026
Next Earnings
17
+ve Days (30d)
13
-ve Days (30d)
OCUL Stock Summary
Last updated Jun 23, 2026
OCUL is currently trading at $10.115, positioned below its 200-day moving average of $10.49, suggesting bearish momentum. The stock has a 52-week range of $6.2301 to $16.44.
Technical Analysis: The 50-day moving average stands at $9.06, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 65.95, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.219, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates OCUL at 57.0/100 with a HOLD recommendation.
OCUL (Ocular Therapeutix, Inc.) Indicators
Last updated Jun 23, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 65.95 |
| CMF (20) | 0.219 |
| ROC (10) | 23.958 |
| ADX (14) | 21.202 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.24 |
| AROONOSC (14) | 64.286 |
| WILLAMS %R (14) | -19.654 |
| MFI (14) | 84.579 |
OCUL Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
OCUL Price vs Max Options Open Interest
OCUL Max Change In Options Open Interest
OCUL Options - Sort by Max open Interest (near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
OCUL Daily Out of Money Options - Sort by Max open Interest (near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
OCUL Daily In the Money Options - Sort by Max open Interest (near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
OCUL Most Active Options by Volume(near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Ocular Therapeutix, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
OCUL Moving Averages Analysis
Ocular Therapeutix, Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jun 23, 2026
OCUL (Ocular Therapeutix, Inc.) Simple Moving Averages
Moving Averages are last updated Jun 23, 2026
| Days | MA |
|---|---|
| 10 | 9.19 |
| 20 | 8.89 |
| 30 | 8.83 |
| 50 | 9.06 |
| 100 | 8.94 |
| 200 | 10.49 |
OCUL Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 2.2 billion |
| Earnings/Share ($) | -1.44 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.55 |
| EPS Estimate Next Year ($) | -1.5225 |
| WallStreet Target Price ($) | 26.9091 |
| Most Recent Quarter |
Ocular Therapeutix's stock $OCUL is on the morning watchlist with entry above $6.80 and target prices of $7.50/$8.00. The company reported positive news regarding its Phase 3 SOL-1 superiority trial meeting its primary endpoint. Despite some panic and overreaction in the market, there is anticipation of a bounce in the stock within 24-72 hours. Trading these low-float stocks can be risky, so it is advised to protect profits and downside according to individual trading plans.
Updated 2026-02-17 15:00:02